SOLESENCE, INC. — Director's Dealing 2018

May 24, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOPHASE TECHNOLOGIES Corp (NANX)
CIK: 0000883107
Period of Report: 2018-05-23

Reporting Person: Cureton Kevin (VP Sales & Mktg & Bus Dev)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-23	Common Stock (right to purchase)	$0.82	A	80000	Acquired	2028-05-23	Common Stock (80000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Common Stock (right to purchase)	$0.30	2022-11-28	Common Stock (52000)	52000	Direct
Common Stock (right to purchase)	$0.415	2023-02-14	Common Stock (48000)	48000	Direct
Common Stock (right to purchase)	$0.52	2024-02-13	Common Stock (75000)	75000	Direct
Common Stock (right to purchase)	$0.44	2025-02-18	Common Stock (50000)	50000	Direct
Common Stock (right to purchase)	$0.42	2026-02-23	Common Stock (43500)	43500	Direct
Common Stock (right to purchase)	$0.68	2027-02-21	Common Stock (50000)	50000	Direct

Footnotes

F1: Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.